EphB2 represents an independent prognostic marker in patients with gastric cancer and promotes tumour cell aggressiveness

Dysregulated expression of ephrin type-B receptor 2 (EphB2) has been linked with the development and progression of solid tumours. In the current study, we attempted to investigate the clinical relevance in GC and the effect of EphB2 expression on gastric cancer (GC) cells. EphB2 protein levels in G...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jie, Li, Zhilei, Ye, Lin, Birkin, Emily, Li, Liting, Xu, Rui, Chen, Guangyong, Ji, Jiafu, Zhang, Zhongtao, Jiang, Wen G., Cui, Yuxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086246/
https://www.ncbi.nlm.nih.gov/pubmed/32226496
http://dx.doi.org/10.7150/jca.38098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086246/
https://www.ncbi.nlm.nih.gov/pubmed/32226496
http://dx.doi.org/10.7150/jca.38098

Ejemplares similares